Inventor
LLINAS-BRUNET MONTSE
CA35 patents
⚠️ This page may combine multiple inventors who share the name “LLINAS-BRUNET MONTSE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM CA LTD
14 patentsUS6608027B1Aug 19, 2003
Macrocyclic peptides active against the hepatitis C virus
BOEHRINGER INGELHEIM CA LTD449 citations99
US6534523B1Mar 18, 2003
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD236 citations99
US6410531B1Jun 25, 2002
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD220 citations99
US6329379B1Dec 11, 2001
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD86 citations99
US6420380B2Jul 16, 2002
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD215 citations98
US6323180B1Nov 27, 2001
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD319 citations98
US6767991B1Jul 27, 2004
Hepatitis C inhibitor peptides
BOEHRINGER INGELHEIM CA LTD115 citations97
US6329417B1Dec 11, 2001
Hepatitis C inhibitor tri-pepitides
BOEHRINGER INGELHEIM CA LTD70 citations97
USRE40525ESep 30, 2008
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD40 citations96
US6143715ANov 7, 2000
Hepatitis C inhibitor peptide analogues
BOEHRINGER INGELHEIM CA LTD74 citations94
US7119072B2Oct 10, 2006
Macrocyclic peptides active against the hepatitis C virus
BOEHRINGER INGELHEIM CA LTD44 citations90
USRE42164EFeb 22, 2011
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
USRE41894EOct 26, 2010
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
USRE41356EMay 25, 2010
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM CA LTD0 citations52
BOEHRINGER INGELHEIM INT
13 patentsUS7091184B2Aug 15, 2006
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM INT114 citations98
US6919423B2Jul 19, 2005
Hepatitis C inhibitor compound
BOEHRINGER INGELHEIM INT86 citations98
US6908901B2Jun 21, 2005
Hepatitis C inhibitor peptide analogs
BOEHRINGER INGELHEIM INT71 citations98
US7585845B2Sep 8, 2009
Hepatitis C inhibitor compounds
BOEHRINGER INGELHEIM INT51 citations96
US6642204B2Nov 4, 2003
Hepatitis C inhibitor tri-peptides
BOEHRINGER INGELHEIM INT129 citations95
US7504378B2Mar 17, 2009
Macrocyclic peptides active against the hepatitis C virus
BOEHRINGER INGELHEIM INT49 citations92
US7939667B2May 10, 2011
Hepatitis C inhibitor compounds
BOEHRINGER INGELHEIM INT20 citations91
US7511157B2Mar 31, 2009
Hepatitis C inhibitor dipeptide analogs
BOEHRINGER INGELHEIM INT15 citations84
US7642235B2Jan 5, 2010
Macrocyclic peptides active against the hepatitis C virus
BOEHRINGER INGELHEIM INT17 citations83
US7705146B2Apr 27, 2010
Hepatitis C inhibitor peptide analogs
BOEHRINGER INGELHEIM INT7 citations62
US7696242B2Apr 13, 2010
Hepatitis C inhibitor peptide analogs
BOEHRINGER INGELHEIM INT2 citations52
US7767818B2Aug 3, 2010
Hepatitis C inhibitor dipeptide analogs
BOEHRINGER INGELHEIM INT1 citations51
US7749961B2Jul 6, 2010
Macrocyclic peptides active against the hepatitis C virus
BOEHRINGER INGELHEIM INT2 citations49
BOEHRINGER INGELHEIM PHARMA
4 patentsUS6268365B1Jul 31, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA31 citations92
US6054470AApr 25, 2000
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA7 citations73
US6284768B1Sep 4, 2001
Src family SH2 domain inhibitors
BOEHRINGER INGELHEIM PHARMA4 citations62
US6156784ADec 5, 2000
Compounds useful as phosphotyrosine mimics
BOEHRINGER INGELHEIM PHARMA4 citations62